Today: 16 April 2026
L’Oréal stock slides in Paris after Asia sales miss — what investors watch next
13 February 2026
1 min read

L’Oréal stock slides in Paris after Asia sales miss — what investors watch next

Paris, Feb 13, 2026, 12:08 CET — Regular session

L’Oreal (OREP.PA) slipped 4.1% to 375.45 euros by 12:05 p.m. in Paris, losing ground from Thursday’s close of 391.65. The CAC 40 was off 0.4%.

L’Oreal shares slipped after the company posted a fourth-quarter like-for-like sales increase of 6%, just shy of the 6.3% analysts had expected. North Asia—mostly China and accounting for about a quarter of L’Oreal’s revenue—managed just 0.6% growth, well below the 5.6% consensus. L’Oreal cited a “challenging” environment for travel retail, with airport duty-free sales still under pressure, but said mainland China is “gradually stabilising”. Before Friday’s session, the stock had climbed about 7% so far this year, trailing Unilever and Beiersdorf. Reuters

The reason this sticks out: market hopes have hinged on a sharper China recovery to drive global beauty players’ growth, with travel retail as the crucial lever. Any shakiness in that area tends to hit 2026 outlooks fast—even if other markets are steady.

L’Oreal shares slid as much as 6% out of the gate, pacing for their steepest drop since October, after investors zeroed in on an unexpected slump in the company’s Asian segment, highlighted by Reuters. Finance chief Christophe Babule told analysts he was aware they “expected more from North Asia,” citing sluggishness in South Korea and softer travel retail demand from mainland China due to domestic airport operator shifts. Over at JP Morgan, analysts flagged the fourth-quarter landscape as making a 2026 top-line acceleration tough to envision, while Deutsche Bank cautioned that earnings growth could lose momentum in the short term. Reuters

European markets saw little movement after the drop. The STOXX 600 hovered near unchanged in the morning, as traders digested uneven earnings and fresh concerns over AI shaking up the landscape. Eyes were on a U.S. inflation readout due this day.

As the session moves on, traders are eyeing whether the stock settles after that initial post-results drop. Estimates are next up, with a sharp focus on North Asia and all things linked to airport duty-free.

Still, there’s an easy risk to flag here: should China keep pinching pennies and travel retail fail to rebound, growth could tilt toward sluggish markets, tightening the margin for error. Suddenly, that “quality” consumer stock doesn’t get any special treatment—it trades like the rest.

L’Oreal’s annual report showed 2025 sales of 44.05 billion euros, a 4.0% rise on a like-for-like basis. Operating margin landed at 20.2%. The board is putting forward a 7.20-euro dividend, with a shareholder vote scheduled for April 24. Shares go ex-dividend April 29 and payment is set for May 4. CEO Nicolas Hieronimus called the outlook for the 2026 global beauty market “optimistic,” though he flagged ongoing macro uncertainties. L’Oréal Finance

Stock Market Today

  • Wheat Prices Rally Approaching March Highs on Strong Demand
    April 16, 2026, 3:34 PM EDT. Wheat futures surged Thursday, with Kansas City Hard Red Winter wheat leading gains, rising 16 to 18 cents in front-month contracts. Chicago Soft Red Winter and Minneapolis spring wheat also climbed, up 5 to 6 cents and 10 to 11 cents respectively. U.S. export sales fell 38.68% week-on-week to 100,318 metric tons but exceeded last year's level by 31.14%. New crop sales reached 131,000 MT, within the forecast range. Taiwan's millers tendered for 105,950 MT of U.S. wheat, while Algeria bought an estimated 400,000 MT of durum wheat, signaling robust international demand. May CBOT Wheat futures traded near $6.00 per bushel mid-session. The market rally reflects ongoing global buying interest and tight supply concerns.

Latest article

Hims & Hers Health Stock Jumps as FDA Reconsiders Peptide Restrictions

Hims & Hers Health Stock Jumps as FDA Reconsiders Peptide Restrictions

16 April 2026
Hims & Hers Health shares rose to $26.65 Thursday after the FDA said it would reconsider restrictions on several peptides, removing 12 from a high-risk list and scheduling a July review of seven more. The move follows Hims’ March decision to stop advertising compounded GLP-1 drugs and expand branded offerings through Novo Nordisk. The company acquired a California peptide facility last year to bolster supply.
NuScale Power Stock Whipsaws After U.S. Opens Door to Nuclear Loans, Space Reactor Push

NuScale Power Stock Whipsaws After U.S. Opens Door to Nuclear Loans, Space Reactor Push

16 April 2026
NuScale Power shares jumped to $13.23 before falling back to $11.52 Thursday after the White House ordered NASA to start a space-reactor program and Energy Secretary Chris Wright said initial U.S. reactors would likely get federal loans. NuScale remains the only U.S. firm with an approved small modular reactor design but has yet to secure firm orders or financing.
SoFi Technologies Stock Rises as FedNow Instant Transfers Set Up April 29 Earnings Test

SoFi Technologies Stock Rises as FedNow Instant Transfers Set Up April 29 Earnings Test

16 April 2026
SoFi Technologies shares rose 1.5% Thursday after launching instant bank transfers via its Galileo platform, allowing money to move between SoFi and outside banks in seconds. The stock traded near $19.08 in New York. Investors await first-quarter results April 29, with SoFi guiding to $1.04 billion in adjusted net revenue and 12 cents per share in adjusted earnings.
D-Wave Quantum Stock Jumps Again as Nvidia’s Ising Launch Reignites Quantum Rally

D-Wave Quantum Stock Jumps Again as Nvidia’s Ising Launch Reignites Quantum Rally

16 April 2026
D-Wave Quantum shares climbed about 5% Thursday, extending a 22.6% surge after Nvidia launched Ising, a new AI model family for quantum computing. D-Wave traded at $21.81, up from last year’s lows, and reported 2025 revenue of $24.6 million with first-quarter 2026 bookings topping $32.8 million. The company completed its $250 million Quantum Circuits acquisition in January. Market cap stood near $8.4 billion.
Algorhythm Holdings (RIME) stock price jumps in premarket as SemiCab AI freight claim keeps traders on edge
Previous Story

Algorhythm Holdings (RIME) stock price jumps in premarket as SemiCab AI freight claim keeps traders on edge

Performance Food Group stock steadies near $98 after an 8% surge — here’s what Wall Street is watching
Next Story

Performance Food Group stock steadies near $98 after an 8% surge — here’s what Wall Street is watching

Go toTop